Due to the strong advocacy by the physician community, the Maryland Department of Health (MDH) is delaying compliance actions of e-prescribing until 1/1/2023 in alignment with the federal CMS postponement. The transmittal can also be found on the OCSA website. A health care practitioner who is unable to electronically transmit prescriptions for controlled dangerous substance drugs may request a waiver from the electronic prescribing requirement under certain circumstances.
MDH is required by legislation to establish a low-volume threshold that will exempt providers who write a minimal number of CDS prescriptions each year. The CMS guidelines have a similar low volume threshold of 100 prescriptions. However, MDH has not yet published regulations that establish that low volume threshold.
Please note that in order to maintain compliance with HG §21-220(c), each provider who wants a waiver will need to submit a request BY JANUARY 1, 2022 and all requests will be granted for this year. If you have missed the deadline, proceed to request a waiver as soon as possible.
You can learn more about this change in a video done by Gene Ransom, MedChi CEO:
Please review carefully and take the necessary actions:
- A health care practitioner who is unable to electronically transmit prescriptions for controlled dangerous substance drugs must request a waiver
- Each provider who wants a waiver will need to submit a request BY JANUARY 1, 2022
- All requested waivers will be granted for the calendar year 2022 only.